Exacerbation Profile in Patients on Mepolizumab for Severe Refractory Eosinophilic Asthma- an Exploratory Study.
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2018
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Apr 2018 Status changed from not yet recruiting to recruiting.
- 01 Nov 2017 New trial record